Chlorambucil PLUS Rituximab As FRONT-LINE Therapy for Elderly and/or Unfit CLL Patients. LONG-TERM Follow-up and Correlation with Biologic-Based Risk Stratification

Laurenti, L; Innocenti, I; Autore, F; Pasquale, R; Vannata, B; Ciolli, S; Mauro, Fr; Mannina, D; Del Poeta, G; D'Arena, G; Massaia, M; Coscia, M; Molica, S; Pozzato, G; Efremov, Dg; Marasca, R; Galieni, P; Cuneo, A; Orlando, S; Piciocchi, A; Boncompagni, R; Vincelli, Di; Liberati, Am; Russo, F; Foa, R